Mid-Atlantic
While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific geographic regions. Therefore, in addition to our disease-specific repurposing communities, we work to increase the repurposing research focused on improving the quality and length of life within the Mid-Atlantic region through the speed and cost-effectiveness of medical repurposing.
Our events and research within the the Mid-Atlantic Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.
Funding Opportunity RFPs for the Mid-Atlantic:
- Repurposing Research to Improve Patient Outcomes in Meniere’s Disease and Related Diagnoses: Clinical and Preclinical Projects: for clinical repurposing trials (budgets up to $350,000) and preclinical repurposing research (budgets up to $100,000) in Meniere’s disease as well as other vertigo and hearing loss-related diagnoses, including benign paroxysmal positional vertigo (BPPV), tinnitus, labyrinthitis and vestibular neuritis. SUBMISSIONS DUE JUNE 13, 2025.
More information on our Funding Opportunities / RFPs page.
Current Mid-Atlantic Trials
Mid-Atlantic: Completed Trials and Press Releases
(in the past 5 years)
Events
Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
November 2021
Virtual
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.
Real World Data Through a Patient’s Lens
October 2021
Virtual
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.
Repurposing for Pediatric Patients: Best Practices and Lessons Learned
November 2020
Virtual
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.
How Patients Impact the 505(b)(2) Regulatory Process
October 2020
Virtual
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.
CureAccelerator Live! for Rare Diseases 2020
June 2020
Virtual
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients.
CureAccelerator Live! for Rare Diseases 2019
June 2019
Philadelphia, PA
Three finalists from the US and Italy competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients.
CureAccelerator Live! for the Developing World 2019
May 2019
Boston, MA
Five finalists from the US and India competing for up to $50,000 to fund their repurposing clinical trials impacting patients in the Developing World.
CureAccelerator Live! for the Mid-Atlantic 2018
October 2018
Washington, DC
Four finalists from Mid-Atlantic institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials.
Latest News
- Cures Within Reach Funds Huntington’s Disease Clinical Trial with Nilotinib at Georgetown
- CHOP Doctor Awarded the American Society for Bone and Mineral Research Frederic C. Bartter Award
- Too Much Stress Will Literally Shrink Your Brain, Experts Warn
- What 'This Is Us' gets right about depression
- Biotech startup rockstar hopes to turn Virginia Tech patents into big business
- Impact of Repurposing on Patients
- Opportunity That Clinical Repurposing Trials Brings to Patients
- How Your Donation to Cures Within Reach Creates Real Patient Impact
- Podcast: Impact Philanthropy Accelerating Cures Within Reach